Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

ACIP logoThe Advisory Committee on Immunization Practices (ACIP) is a group of medical and public health experts that develop recommendations on use of vaccines in the civilian population of the United States...



Register for upcoming February ACIP meeting

February 22-23, 2017

Deadline for registration:
Non-US Citizens: February 1, 2017
US Citizens: February 13, 2017

Registration is NOT required to watch the live meeting webcast or to listen via telephone.

Public Comment Instructions [1 page]

ACIP Recommendations

General Committee-related Information

  • Charter
    Defines ACIP's purpose, authority, and function; its structure, meetings, and compensation; plus costs, reports, and termination.
  • Members
    Membership roster, including chair, executive secretary, voting members, ex officio members, and liaison representatives.
  • Articles
    Journal articles about the ACIP.


ACIP Flyer

ACIP brochure This ACIP flyer [2 pages] answers questions such as what does the ACIP consider in the vaccine recommendation process, including recommended ages for administration of various vaccines to children?

ACIP Votes, June 2016

  • ACIP approved the following three recommendations by majority vote on June 22, 2016:
    • Cholera vaccine (CVD 103-HgR, Vaxchora™) is recommended for adult (18-64 years old) travelers to an area of active cholera transmission.
    • Influenza vaccine: In light of concern regarding poor effectiveness against influenza A(H1N1)pdm09 in the U.S. during the 2013-14 and 2015-16 seasons, for the 2016-17 season, ACIP makes the interim recommendation that live attenuated influenza vaccine (LAIV4) should not be used.
    • Meningococcal vaccine: Persons aged ≥2 years with HIV infection who have not been previously vaccinated should receive a 2-dose primary series of MenACWY (0, 2 months). Children 2 months through ≤2 years with HIV infection should receive an age appropriate series of MenACWY.
  • If approved by the CDC Director, the recommendations will become official once published in MMWR.

ACIP Meetings